About the Authors

Nadia Neuner-Jehle

Roles Conceptualization, Formal analysis, Funding acquisition, Writing – original draft, Writing – review & editing

nadia.neuner-jehle@bluewin.ch (NNJ), roger.kouyos@uzh.ch (RDK)

Affiliations Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland, Institute of Medical Virology, University of Zurich, Zurich, Switzerland

Marius Zeeb

Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

Affiliations Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland, Institute of Medical Virology, University of Zurich, Zurich, Switzerland

Christian W. Thorball

Roles Formal analysis, Resources, Writing – review & editing

Affiliation Precision Medicine Unit, Biomedical Data Science Center, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

Jacques Fellay

Roles Resources, Writing – review & editing

Affiliations Precision Medicine Unit, Biomedical Data Science Center, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland, Swiss Institute of Bioinformatics, Lausanne, Switzerland

Karin J. Metzner

Roles Resources, Writing – review & editing

Affiliations Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland, Institute of Medical Virology, University of Zurich, Zurich, Switzerland

Paul Frischknecht

Roles Formal analysis, Resources, Writing – review & editing

Affiliation Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland

Kathrin Neumann

Roles Resources, Writing – review & editing

Affiliation Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland

Christine Leeman

Roles Resources, Writing – review & editing

Affiliation Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland

Andri Rauch

Roles Resources, Writing – review & editing

Affiliation Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland

Marcel Stöckle

Roles Resources, Writing – review & editing

Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland

Michael Huber

Roles Resources, Writing – review & editing

Affiliation Institute of Medical Virology, University of Zurich, Zurich, Switzerland

Matthieu Perreau

Roles Resources, Writing – review & editing

Affiliation Divisions of Immunology and Allergy, Lausanne University Hospital, Lausanne, Switzerland

Enos Bernasconi

Roles Resources, Writing – review & editing

Affiliation Division of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, University of Geneva and University of Southern Switzerland, Lugano, Switzerland

Julia Notter

Roles Resources, Writing – review & editing

Affiliation Division of Infectious Diseases, Infection Prevention and Travel Medicine, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

Matthias Hoffmann

Roles Resources, Writing – review & editing

Affiliation Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital Olten, Olten, Switzerland

Karoline Leuzinger

Roles Resources, Writing – review & editing

Affiliation Clinical Virology, University Hospital Basel, Basel, Switzerland

Huldrych F. Günthard

Roles Conceptualization, Writing – original draft, Writing – review & editing

Affiliations Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland, Institute of Medical Virology, University of Zurich, Zurich, Switzerland

Chloé Pasin

Contributed equally to this work with: Chloé Pasin, Roger D. Kouyos

Roles Conceptualization, Formal analysis, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing

Affiliations Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland, Institute of Medical Virology, University of Zurich, Zurich, Switzerland, Collegium Helveticum, Zurich, Switzerland

Roger D. Kouyos

Contributed equally to this work with: Chloé Pasin, Roger D. Kouyos

Roles Conceptualization, Formal analysis, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing

Affiliations Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland, Institute of Medical Virology, University of Zurich, Zurich, Switzerland

the Swiss HIV Cohort Study (SHCS)

Membership of Swiss HIV Cohort Study (SHCS) is provided in Supporting Information file S1 Acknowledgments.

Competing Interests

K.J.M. has received travel grants and honoraria from Gilead Sciences, Roche Diagnostics, GlaxoSmithKline, Merck Sharp & Dohme, Bristol-Myers Squibb, ViiV, and Abbott; and the University of Zurich has received research grants from Gilead Science, Novartis, Roche, and Merck Sharp & Dohme for studies in which K.J.M. serves as principal investigator, and advisory board honoraria from Gilead Sciences and ViiV. A.R. reports support to his institution for advisory board and/or travel grants from MSD, Gilead Sciences, Pfizer, and Moderna, and an investigator-initiated trial (IIT) grant from Gilead Sciences. All honoraria went to his home institution, not to A.R. personally, and all honoraria were provided outside of the submitted work. M.S. reports advisory board consultations from Gilead, ViiV, MSD, paid to his institution, and travel grants for conferences from Gilead, paid to his institution. E.B.’s institution has received research grants from Gilead and Merck unrelated to this work; E.B.’s institution has also received consultancy fees and travel grants from Gilead, ViiV, Merck, Pfizer, Astra Zeneca, Moderna, Abbvie, and Ely Lilly. J.N. has received travel grants from Gilead. H.F.G. has received grants from the Yvonne-Jacob Foundation, the Clinical Research Priority Program of the University of Zurich, and Gilead Sciences, and, outside of this study, grants for unrestricted research from the Swiss HIV Cohort Study, the Swiss National Science Foundation, the National Institutes of Health, the Bill and Melinda Gates Foundation, Gilead, and ViiV; and personal fees as a consultant for Merck, ViiV Healthcare, and Gilead Sciences and as a member of the Data and Safety Monitoring Board for Merck. H.F.G.’s institution has received educational grants unrelated to this work from Gilead, ViiV, MSD, Abbvie, Pfizer, and Sandoz. C.P. has received fellowships from the Collegium Helveticum. R.D.K. has received grants from Gilead Sciences, the National Institutes of Health, the Swiss National Science Foundation, and the Swiss HIV Cohort Study. N.N.J. has received support from the Swiss National Science Foundation and the Swiss HIV Cohort Study. All other authors report no potential conflicts of interest.